These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 8058587

  • 1. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
    Sofia RD, Gordon R, Gels M, Diamantis W.
    Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
    [Abstract] [Full Text] [Related]

  • 2. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
    De Sarro G, Ongini E, Bertorelli R, Aguglia U, De Sarro A.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):11-9. PubMed ID: 7529182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
    Coffin V, Cohen-Williams M, Barnett A.
    Eur J Pharmacol; 1994 Apr 21; 256(2):R9-10. PubMed ID: 8050461
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.
    Tomczyk T, Haberek G, Zuchora B, Jarosławska-Zych A, Kowalczyk MS, Wielosz M, Urbańska EM.
    Pharmacol Rep; 2007 Apr 21; 59(4):462-6. PubMed ID: 17901576
    [Abstract] [Full Text] [Related]

  • 7. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
    Gordon R, Gels M, Wichmann J, Diamantis W, Sofia RD.
    Epilepsia; 1993 Apr 21; 34(2):367-71. PubMed ID: 8453946
    [Abstract] [Full Text] [Related]

  • 8. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
    Kleckner NW, Glazewski JC, Chen CC, Moscrip TD.
    J Pharmacol Exp Ther; 1999 May 21; 289(2):886-94. PubMed ID: 10215667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
    Taylor LA, McQuade RD, Tice MA.
    Eur J Pharmacol; 1995 Apr 28; 289(2):229-33. PubMed ID: 7621896
    [Abstract] [Full Text] [Related]

  • 12. Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.
    Gordon R, Gels M, Diamantis W, Sofia RD.
    Pharmacol Biochem Behav; 1991 Sep 28; 40(1):109-13. PubMed ID: 1664105
    [Abstract] [Full Text] [Related]

  • 13. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor".
    Rogawski MA, Wasterlain CG, Mazarati AM.
    Epilepsia; 2000 Jul 28; 41(7):918-9. PubMed ID: 10897169
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat.
    Sofia RD, Gordon R, Gels M, Diamantis W.
    Res Commun Chem Pathol Pharmacol; 1993 Mar 28; 79(3):335-41. PubMed ID: 8480078
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
    Domenici MR, Marinelli S, Sagratella S.
    Life Sci; 1996 May 24; 58(26):PL391-6. PubMed ID: 8691980
    [Abstract] [Full Text] [Related]

  • 19. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice.
    Gasior M, Swiader M, Przybyłko M, Borowicz K, Turski WA, Kleinrok Z, Czuczwar SJ.
    Eur J Pharmacol; 1998 Jul 10; 352(2-3):207-14. PubMed ID: 9716356
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.